Trial intelligence / Profile preview

Intravenous ibuprofen versus morphine + paracetamol for platelet function during elective craniotomy

IRCT20210506051200N1Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Jun 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of ibuprofen, morphine and acetaminophen in supratentorial brain lesion, sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Blood platelet function and Pain. Started Jun 2021; status: completed.

02

Drugs

ibuprofenmorphineacetaminophen
03

Conditions

supratentorial brain lesion

Beyond the preview

Go deeper on IRCT20210506051200N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210506051200N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call